Creyos
PrivateLast Round
Debt
Jul 24, 2023
Total Funding Raised
$6.3M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Creyos operates in Healthcare & Life Sciences and is based in Toronto. Its latest recorded funding round was a Debt round in July 2023.
Creyos is a healthcare technology company that provides a web-based platform for the assessment of brain health and cognitive function.
Sector
Healthcare & Life Sciences
Verticals
Mental Health, Healthcare Analytics, Clinical Trials, Vertical SaaS
Business Model
B2B
Customer Profile
Subscription SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Creyos Comparables
Compare Creyos with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| BrainCheck | 90% | |
| Neurotrack Technologies, Inc. | 88% | |
| CNS Vital Signs | 83% |
For institutional investors. Book with your work email.
Creyos Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Debt | Jul 24, 2023 | ||||
| Seed | Oct 1, 2021 | ||||
| Grant | Mar 12, 2021 | ||||
| Growth Equity | Mar 1, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Creyos Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| The Impact Engine | Seed |
| Real Ventures | Seed |
| Export Development Canada | Seed |
| EduLab Capital Partners | Seed |
| Canada's Digital Technology Supercluster | Grant |
| Canadian Shield Capital | Growth Equity |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 26, 2026
Added MedStar Health, an enterprise healthcare organization, as a customer.
- Jul 26, 2026
Added Eventus WholeHealth, a mid-market healthcare company, as a customer.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- signs_new_clientAug 10, 2026
Creyos signs ClareMedica Health Partners, LLC as a new client for digital cognitive and behavioral health assessment across more than 35 Florida senior care sites on Aug 10th '26.
For institutional investors. Book with your work email.
Creyos Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Creyos's valuation, stock price, and market status.
Is Creyos a public or private company?
Creyos is a private company.
What is the current stock price of Creyos?
Creyos is a private company, so its shares have no public market price. Caplight tracks Creyos's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Creyos worth (valuation)?
Valuation information for Creyos is not publicly available.
Can I buy Creyos stock?
Creyos shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Creyos's last funding round?
Creyos's most recent funding round was Debt on July 24, 2023.
Who are the main investors in Creyos?
Key investors in Creyos include Real Ventures, Canada's Digital Technology Supercluster, Canadian Shield Capital.
Will Creyos IPO soon?
No public IPO plans have been announced for Creyos.
How can I track Creyos secondary market activity?
Caplight tracks bids, offers, and trades in Creyos's shares on secondary markets.